7-Ethylcamptothecin CAS:78287-27-1 is a powerful camptothecin derivative, characterized by its modified functional group containing an ethyl moiety at the 7-position. This alteration enhances the compound’s lipophilicity, improving cellular uptake and bioavailability. As a potent DNA topoisomerase I inhibitor, 7-Ethylcamptothecin exhibits remarkable antitumor properties and plays a crucial role in cancer research and therapeutic development.
The compound’s primary use is in the design of targeted cancer therapies, where it disrupts DNA replication and transcription processes in cancer cells, ultimately inducing apoptosis. By leveraging the unique features and capabilities of 7-Ethylcamptothecin, researchers are paving the way for more effective and safer cancer treatments, pushing the boundaries of oncology and patient care.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
